Discovery & Development Europe 2027
June 2027
Basel, Switzerland
Basel, Switzerland
.png?width=300&height=147&name=Drug%20Discovery%20Europe%202026%20Updated%20(Dark).png)
.png?width=330&height=106&name=Formulation%20%26%20Delivery%20Europe%202026%20Updated%20(Dark).png)
Amardeep Singh Bhalla
Executive Director,
Regeneron
Andreas Bernkop Schnürch
Professor,
Innsbruck University
Andreas Seidl
Chief Scientific Officer,
Formycon
Andreas Gryczke
ACoS Research Fellow,
AbbVie
Bjarki Johannesson
Director, Safety Innovation,
AstraZeneca
Covadonga Paneda
Chief Operating Officer,
Altamira Therapeutics AG
Dave Hallett
Chief Scientific Officer,
Recursion Pharmaceuticals
Emma Mead
Chief Scientific Officer,
ARUK Oxford Drug Discovery Institute
Fatma Salahioglu
Senior Programme Manager,
Resolian
Ingo Hartung
Executive Director, Global Head of Medicinal Chemistry & Drug Design,
Merck & Cie KmG
Jean-Philippe Courade
Chief Scientific Officer,
Discoveric bio alpha
-457a7b.jpg?length=600&name=d506ffda-24d0-4cd4-b7f2-015f8e8086b3-2-11764368speaker_photo-Jenifer-Mains_0265_V1-(4)-457a7b.jpg)
Jenifer Mains
Senior Director, Formulation Science ,
Bicycle Therapeutics
Jens Frauenfeld
Chief Executive Officer,
Salipro Biotech
Liam Good
Chief Scientific Officer,
Tecrea
Liuhong Chen
Vice President, Platform Innovation,
Bicycle Therapeutics
Magnus Ivarsson
Chief Scientific Officer,
astronautx.bio
Paul Workman
Harrap Professor of Pharmacology and Therapeutics,
The Institute of Cancer Research, London
Peyman Gifani
Founder & Chief Executive Officer,
AI VIVO
Rafal Kaminski
Chief Scientific Officer,
Angelini Pharma
Ruth Shah
Head of Bayer Co.Lab Berlin,
Bayer
Samir Mitragotri
Professor,
Harvard University
Shadi Farhangrazi
Chief Executive Officer,
S. M. Discovery Group (SMDG)
Sheila Peters
Executive Director and Early Asset Lead,
Boehringer Ingelheim
Steinunn Sara Helgudottir
Chief Scientific Officer,
Neurometa Therapeutics
Susanne Muller-Knapp
Chief Operating Officer,
The Structural Genomics Consortium
-0c413b.jpg?length=600&name=140be691-26e6-4386-b99a-c414e36acf84-2-11764368speaker_photo-ScheubleTheresa-(3)-0c413b.jpg)
Theresa Scheuble
R&D Director, Drug Delivery Systems,
Johnson & Johnson Innovative Medicines
Abhishek Choudhary
Principal Data Engineer,
Bayer
-3fd782.jpg?length=600&name=dbfd5d64-5154-4e4f-a571-3f0be263d111-2-11764368speaker_photo-%C2%A9Delporte-AishwaryaParthasarathy03MoyenneDef-(2)-3fd782.jpg)
Aishwarya Parthasarathy
Associate,
Sofinnova Partners
Alex Ide
General Manager,
Genomics
Amal Ali Elkordy
Professor of pharmaceutics,
University of Sunderland
Anselm Schneider
Head of Laboratory in Lead Discovery,
Nuvisan ICB GmbH
Arianna Sabò
Head of R&D,
Quantro
Austin Gamble Jarvi
Applications Manager,
High Q Technologies
Avinash Murthy
Drug Product Lead,
Roche
Bilada Bilican
Senior Director,
Applied Stem Cell Sciences - Centre for Genomics Research, AstraZeneca
Birgitta Leuthner
Scientific Director,
Merck Healthcare Kgaa
Carsten Spannhuth
Chief Scientific Officer,
ateka|tx
Cathy Vickers
Head of Innovation,
NC3Rs
Cerlin Roberts
CEO,
Oxford Global
Chris Hamlett
Director,
Astex Pharmaceuticals
Christian Klein
Business Development Manager EMEA,
Lonza Capsules & Health Ingredients
Christian Lotz
General Manager EMEA,
Pfanstiehl
Christian Pilger
Director,
AbbVie
Christina Theisgen
Senior Global Product Trainer,
Cell Signaling Technology
Chuang Kee Ong
Director Data Product,
GSK
Cristina Hidalgo
Senior Automation Scientist,
AstraZeneca
Csaba Peltz
Director of Chemistry,
Certara
Cyril Teixeira da Silva
Investment Officer, Growth Finance & Venture Debt,
European Investment Bank
-ad0b4d.png?length=600&name=c04f5793-e038-41f8-964e-6c8d335cde93-2-11764368speaker_photo-David-Heinz_DSC02618-1_Q1-(1)-ad0b4d.png)
David Heinz
Board Member,
SiLA
Dhwani Rana
Senior Scientist,
RCPE
Dr. Mathias Gschell
Head of Cryo-EM ,
Bimovis
Duy Trieu Trieu
Chief Technology Officer,
NYB.AI
-bc73db.jpg?length=600&name=349b9314-5dc1-450e-af7f-824f006f78e9-2-11764368speaker_photo-2023-Headshot_Elena-Fernandez-Kleinlein-2023-(1MB)-bc73db.jpg)
Elena Fernandez-Kleinlein
Head of JLABS EMEA,
Johnson & Johnson
Eliot Morrison
Principal Scientist, Head of Molecular Design Biology,
Silence Therapeutics
Elisabetta Leo
ED Global Asset Lead,
Ipsen
Emma Murphy
Head of Biology,
Centre for Medicines Discovery
Eric Munson
Professor,
Purdue University
Eszter Sutowski Nagy
Senior Production Director,
Oxford Global
Fabrizio Ricci
Senior Scientist,
Johnson & Johnson Innovative Medicine
Felix Hausch
Professor for Structure-Based Drug Research,
TU Darmstadt
Florian Ries
Principal Research Scientist I,
AbbVie
Freya Trasischker
Senior Applications Scientist,
Chemical Computing Group
Friedrich Sarrazin
Co-Founder,
Addimus Bio
Gerhard Wolber
Professor of Medicinal Chemistry,
Epiios Therapeutics
Gisbert Schneider
Full Professor of Computer-Assisted Drug Design,
ETH Zürich
Goran Verspui
Head of Drug Development ,
Symeres
Gustavo Gutierrez
Director,
AstraZeneca
Hongbo Zhang
Chief Scientific Officer,
HitChem
Ib Vestergaard Klewe
Senior Director, Head of Area, External Partnering Lead, Early Research & Innovation,
Lundbeck
Ildiko Terebesi
Scientific Consultant ,
INVITE GmbH
Ingo Kober
Director Emergent Modalities Pharmacology,
Merck Healthcare KGaA
Ionel Mangalagiu
Professor,
Alexandru Ioan Cuza University Of Iasi
Jack Palmer
Field Application Scientist Europe,
Nova biomedical
Jamie Cartland
Client Partner, EMEA,
Causaly
Jan Schäfer
Senior Field Application Scientist EMEA – Global Distribution Support,
Redshift Bio
Jarrod Walsh
Director – Affinity Screening,
AstraZeneca
Jean Ge
Patent Attorney,
Wolf Greenfield
Jenny Karlsson
Senior Director - Targeted Radiopharmaceuticals,
Bayer
Johan Pihl
Chief Scientific Officer,
Cellectricon AB
Johannes Krupp
Research Program Director Neurology,
Servier
Jordan Bye
Principal Formulation Development Scientist,
Immunocore
Jorge Dias
Director Antibody Discovery,
Alchemab Therapeutics
Josephine Blersch, PhD
Screening & Data Scientist,
DZNE
Josh Bagley
Chief Scientific Officer,
AheadBio
Kamalinder Singh
Professor of Pharmaceutical Technology & Drug Delivery,
University of Lancashire
Karl Box
Chief Scientific Officer,
Pion Inc
Katie Beckwith
Machine Learning Engineer,
Ignota Labs
Katja Rosti
COO,
Avenue Biosciences
Kelly Gray
Senior Alliances Manager,
Ignota Labs
Kenan Pandza
VP of R&D,
Persist AI
Keqian Nan
Application Scientist ,
AcoustoFab
Kevin Gonzales
Principal Scientist,
Novo Nordisk
Kilian Huber
Associate Professor, Senior Group Leader Chemical Biology & Chemical Probes,
University of Oxford
Kimberly Shepard
Director, Advanced Drug Delivery,
Lonza
Konstantinos Gkatzis
Chief Executive Officer,
Epiceller
Kristine Freude
Professor,
University Copenhagen
Kristof Schuett
Senior Principal Machine Learning Research Scientist,
Pfizer Ltd
Krzysztof Brzózka
Chief Scientific Officer,
Ryvu Therapeutics
-d9fb86.jpg?length=600&name=714ba00d-6f2d-4791-a51e-a0e4bc0c3b6c-2-11764368speaker_photo-Kurt-Photo-2-2021-(3)-d9fb86.jpg)
Kurt Pike
Senior Director, External Innovation,
Johnson & Johnson
Laurent Gomez
Senior Vice President & Head of Discovery,
Iambic Therapeutics
Leena Otsomaa
Vice President, Head of Medicine Design,
Orion Corporation, Orion Pharma
Lian Rajewski
Senior Director Formulation Development,
Ligand Pharmaceuticals (CyDex Pharmaceuticals)
Lucas Bethge
Vice President, Group Leader Oligonucleotide Chemistry,
Silence Therapeutics
Magdalena Kierkowicz
Senior Scientist,
UCB
Mahendra Deonarain
Chief Executive Officer,
Antikor Biopharma Ltd
Main Speaker: Atsushi Kaga, Scientist, SPERA PHARMA
Invited speaker: Emilia Buchsteiner, Application Scientist, Rigaku ,
Marc Porr
Chief Executive Officer & Founder, TechkIT & SiLA Director and Head of Cyber Security Work Group,
TechkIT GmbH; SiLA
Marc Siggel
Associate Director, Head of Digital for Next Gen Drug Delivery,
Merck KGaA
Marianne Gentric
Drug Product Team Leader,
Sanofi
Mark Eccleston
Chief Executive Officer,
ValiRx
Marta Koper
Senior Scientist,
UCB
Martin Kriebel
Senior Principal Scientist, Next Generation Cellular and Organotypic Assays,
NMI
Matt Clark
CSO,
X-Chem
Matthew Segall
CEO,
Optibrium
Matthew Todd
Professor & Head of Global Research Collaborations,
University College London & Structural Genomics Consortium
Matthias Gehringer
Professor,
University of Tuebingen
Max Salm
Senior Director, Target Sciences,
Bicycle Therapeutics
Mazdak Asadian-Birjand
Principal Chemist,
Sapreme Therapeutics
Michael Gosselin
Vice President, Pharmaceutical Development,
Aprecia
Michael Johnson
Professor of Neurology and Genomic Medicine,
Imperial College London
Min Shan
Associate Director of ADC Chemistry in MCDD, Discovery and Development Technologies, Merck Healthcare KGaA,
Merck Healthcare KGaA
Mitul Mehta
Professor,
King's College London
-2bb66e.jpg?length=600&name=9d70857b-7412-4d71-a157-3bf5f6163122-2-11764368speaker_photo-20260304_165111(2)-2bb66e.jpg)
Moh Tadayyon
Co-founder,
Apeikon Therapeutics
Mohammed Shahid Uddin
Senior Director,
Immunocore
Nicola Chessum
Principal Scientist,
Boehringer Ingelheim
Nicola Vettore
Customer Engagement Scientist,
Collaborative Drug Discovery, Inc. (CDD)
Nicolas Schwenck
Head of Business Development & Partnerships,
EbenBuild
Parmi Shah
CEO,
Rasayan Labs
Peter Bitsch
Conjugation Specialist, Next Gen Drug Delivery,
Merck
Peter Donnelly
Chief Executive Officer,
Genomics plc
Philip Christophersen
Principal Scientist in Oral Formulation Research,
Novo Nordisk
Piyush Agrawal
Data Science Manager,
CAS
Preben Bruun-Nyzell
Chief Executive Officer,
Neurometa Therapeutics
Ricardo de la Torre Gonzalez & Daniel Garcia Gonzalez
Co-founders & CEO and CSO (Respectively),
60Nd
Rick Ewing
Vice President, Head of Chemistry,
Rapafusyn
Robert Byrne
Head of Structural Biology,
CRELUX, A Wuxi AppTec Company
Robin Roehm
Chief Executive Officer,
Apheris AI GmbH
Roman Schulte-Sasse
Head of Data Science Discovery,
Aignostics GmbH
Ross Wheatcroft
Business Development Manager EMEA & APAC,
Sabrina Stöckl
Principal,
b2venture
Sam Dylan Moré
CEO and Founder,
Dendropharm GmbH
Sanne Holt
Associate Director immuno-oncology,
Ncardia
Simon Gilbert
Associate Director Bioscience,
Amphista Therapeutics Ltd
Søren Nielsen
Scientific Senior Director,
Amgen
Stefan Hauser
Group Leader,
DZNE (German Centre for Neurodegenerative Diseases)
Stefan Knapp
Professor,
Goethe University Frankfurt
Stefan Schiesser
Director of Medicinal Chemistry,
AstraZeneca
Steffen Renner
Associate Director Data Science,
Novartis
Steve Amoussou-Guenou
Customer Solutions Manager,
Sune Klint Andersen
Scientific Associate Director,
Janssen Pharmaceutical Companies of Johnson & Johnson
Suruchi Vishwasrao
Senior Scientist,
Merck & Cie KmG
Takashi Ebihara
COO,
GeneFrontier Corporation
Tanvir Tabish
Director, Early Formulation Development,
AstraZeneca
Thijs Cui
Principal Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson
Tomaso Guidi
Head of Formulation and Process Development,
Chiesi Farmaceutici SpA
Valeriya Shunina
Investor,
Earlybird VC
Vijay Chandrasekar
Associate Principal Scientist,
AstraZeneca
Vijaya Lakshmi Kari
Group Leader,
Evotec
Vijayavittha Mathad
Chief Operating Officer,
Cramsn
Vinay Pawar
Director, R&D External Innovation,
Novo Nordisk A/S
-2aaf39.jpg?length=600&name=08ae7676-0965-45a1-9312-ecf7b7c6ba62-2-11764368speaker_photo-Iktos-Yann-Gaston-Math%C3%A9-(1)-2aaf39.jpg)
Yann Gaston-Mathe
Co-Founder and Chief Executive Officer,
Iktos AI
Yuhei Onizuka
Research Scientist, Life Science Research Laboratory,
NOF CORPORATION
Zameel Cader
Director, Oxford Headache Centre & Professor of Neuroscience & Neurology,
University of Oxford
Zoran Rankovic
Professor of Chemical Biology & Director, Centre for Protein Degradation,
The Institute of Cancer Research
Last Year's Sponsors of Discovery & Development Europe 2026
Gold Sponsors
Causaly Ltd
Gold Sponsor
Causaly is the leading Agentic AI research platform for life sciences, designed to accelerate R&D through scientifically grounded, autonomous research workflows. Our agentic research capability orchestrates multi-step investigations by retrieving, analyzing, and synthesizing evidence across millions of scientific publications and data sources to deliver transparent, evidence-backed insights.
Built on a proprietary knowledge graph of over 500 million evidence points, Causaly enables researchers to uncover disease mechanisms, identify novel targets, evaluate biomarkers, assess safety signals, and understand the competitive landscape. Trusted by leading biopharma organizations, Causaly supports decision-making across the full R&D lifecycle. From early discovery and translational research through clinical development and beyond, helping teams move from complex data to confident decisions faster.
Silver Sponsors
BioDuro
Silver Sponsor
BioDuro is a US company founded in 1996, and headquartered in Irvine, California. With more than 2,000+ scientists, we have 7 R&D and manufacturing campuses across the US and China. We offer fully integrated CRDMO services from discovery to commercial manufacturing across medicinal chemistry, biology, DMPK, drug substance and drug product, including multiple modalities small molecules, peptides, oligonucleotides and antibody drug conjugates.
We leverage our broad capabilities and unique technology platforms to empower biotech and pharmaceutical partners worldwide. Our integrated approaches accelerate and de-risk new drug discovery and development, creating higher value outcomes for our clients. Committed to the highest standards of compliance and business operations, we maintain a science-driven, customer-oriented, innovative and people-focused culture.
As a pure-play CRDMO, BioDuro operates under one global standard, providing integrated, fast, and flexible services to meet the unique needs of our clients and accelerate development timelines.
bit.bio
Silver Sponsor
bit.bio designs and manufactures human cells to advance drug discovery and biomedical research. Using our proprietary deterministic cell programming technology, opti-ox, we convert induced pluripotent stem cells (iPSCs) into any human cell type in one step. Our AI powered discovery platform identifies unique combinations of transcription factors that can program any desired cell type with exceptional purity and consistency at scale. Globally available, the ioCells™ portfolio features 55 products including: ioWild Type Cells, ioDisease Model Cells, CRISPR-Ready ioCells, and ioTracker Cells.
Cadence
Silver Sponsor
Cadence Molecular Sciences (OpenEye) offers state-of-the art solutions in computational molecular design through consulting services, robust and scalable software for the desktop, and Orion®, a cloud-native, software-as-a-service (SaaS) molecular modeling platform. Combining massive scale computation and storage with powerful tools for data sharing, visualization and analysis in a customizable development environment, Orion offers unprecedented capabilities for the discovery of small molecule drugs, biologics, agrochemicals, and flavors and fragrances.
-722729.png?length=600&name=c0141b3e-a539-4a53-848b-b9652e8d43ab-2-5668375logo-Certara-Chemaxon-logo-horizontal-red-(3)-722729.png){kind=logo}
Chemaxon LLC
Silver Sponsor
Transforming drug discovery and development for good
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries.
Certara acquired Chemaxon in 2024 to close gaps in the design-make-test-analyze cycle, bring promising leads into biosimulation, and speed up the launch of new medicines. Together, we help you innovate with confidence by turning your discovery process into a competitive advantage.
We will present our cheminformatics software solutions for chemical drawing, molecule design, data analysis, and compound data management alongside our latest AI developments.
Learn more at: https://www.certara.com/chemaxon/
High Q Technologies
Silver Sponsor
High Q Technologies, based in Waterloo, Ontario, develops quantum-enabled EPR systems that help structural biologists, pharmaceutical researchers, and biotechnology teams resolve complex problems in protein dynamics and biomolecular structural determination. Our flagship instrument, FATHOM®, the world’s first quantum-enabled EPR spectrometer, provides high-resolution insights into protein conformations, distance distributions, and dynamics, generating detailed, publication-ready reports for each sample. FATHOM's innovative resonator design and automated workflows enable load-and-go operation across multiple samples, reduce acquisition times from days to hours and capture protein motions that are difficult or impossible with traditional structural biology techniques. As a complementary technique to Cryo-EM, AlphaFold predictions, and molecular dynamics simulations, FATHOM provides information on conformational dynamics, giving researchers practical insights into protein behavior. In addition to instruments, High Q Technologies offers a Sample Measurement Service (SMS) that gives researchers immediate access to high-resolution EPR data without the need for in-house equipment. SMS provides flexible options, from single-sample analyses to fully managed measurement pipelines, including custom experimental design, pilot studies, and collaboration with our scientists for method development and data interpretation. For more information about FATHOM EPR or our Sample Measurement Service, contact us at www.highqtechnologies.com.
Hit Chem
Silver Sponsor
HitChem integrates advanced cheminformatics and cutting-edge language models to accelerate early-stage small molecule drug discovery. Our proprietary platform combines AI-driven molecule design with ultra-high-throughput screening to speed up hit identification and lead generation.
Nanyang Biologics
Silver Sponsor
NYB.AI is a Pre-IPO AI-native biotechnology company that maps indication biology, models drug–target interactions, predicts out-of-domain bioactivity and connects discovery data — end-to-end, in one platform, enabling pharma and biotech to improve upstream target confidence and hit quality. We were featured in the most recent Keynote by Jensen Huang at GTC Taiwan, occurred 1 June.
NOF Europe GmbH
Silver Sponsor
NOF CORPORATION, the leading commercial supplier of drug delivery products through R&D to commercial scale, provides activated PEGs for protein modification, single molecular PEGs for ADCs, Polysorbate 80 for formulation of biological medicines, PEG lipids and ionizable lipids for lipid nanoparticle (LNP) formulations. NOF's LNP platform composed of COATSOME® SS Series, novel biodegradable ionizable lipid, demonstrates superior endosomal escape and provides high protein expression with extremely low systemic toxicity. The platform can be applied to gene delivery, gene editing, nucleic acid vaccine and in vitro transfection. It is capable of encapsulating pDNA, siRNA and mRNA, and delivering these to various organs and tissues. NOF’s LNP platform is becoming adopted in clinical planning by NOF collaborators.
SAI Life Sciences
Silver Sponsor
Sai Life Sciences is one of India’s fastest-growing CRDMOs. We work with 300+ global pharmaceutical and biotech innovators, including 19 of the top 25 large pharma companies, to accelerate the drug discovery, development, and manufacturing of small molecule new chemical entities (NCEs). With over 3800 employees across our facilities in UK, USA and India, we support innovators across the entire drug discovery journey from concept to commercialisation, including exploratory biology, creative chemistry, DMPK, toxicology, early phase development, process & analytical development, scale-up, tech transfer, clinical supplies and cGMP manufacturing. Over the past 27+ years, we have built our business on the foundation of mutual trust and client focus, consistently delivering value based on our scientific strength and responsiveness. For more information, visit www.sailife.com
Bronze Sponsors
AcroBiosystems
Bronze Sponsor
ACROBiosystems Group, founded in 2010, is a global biotechnology company with offices and R&D centers across the US, Europe, and China. It partners with leading pharma companies including Pfizer, Novartis, Bayer, Merck, and Johnson & Johnson.
ACROBiosystems offers proteins, kits, antibodies, and scientific services to support drug development and global health.
BrainXell
Bronze Sponsor
Industry leading producer of neurons and glia paving the way for advancements in neuroscience.
BrainXell was established in 2015 by Dr. Su-Chun Zhang, a pioneer in stem cell neuroscience, in collaboration with the University of Wisconsin–Madison’s Discovery to Product (D2P) program, to translate cutting-edge research into meaningful therapies. Today, the team works with both large and small biotech and pharmaceutical partners to develop products, services, and applications using its proprietary technology to guide human stem cells—including induced pluripotent stem cells (iPSCs)—into highly enriched, specialized neurons. BrainXell is working to bring hope to patients with neurological conditions.
Our company is based on directed differentiation of human stem cells (including iPSCs) to highly enriched subclasses of neurons. BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. From motor neurons to cortical sub-types, we can provide specific models for both disease or normal drug screening. We are dedicated to delivering the highest quality products from both our off-the-shelf neurons as well as custom service projects.
CAS
Bronze Sponsor
CAS connects the world's scientific knowledge to accelerate breakthroughs that improve lives. We partner with global innovators to navigate today’s increasingly complex data landscape and uncover opportunities that drive meaningful progress. As specialists in scientific knowledge management, our team builds the world's largest, authoritative collection of human-curated scientific data and applies advanced technologies, proprietary capabilities, and deep domain expertise to solve our clients’ most difficult information challenges. Our unique combination of world-class content, technology, and data management expertise helps global innovators scale AI and drive innovation. CAS is a division of the American Chemical Society.
Cell Signaling Technology
Bronze Sponsor
Cell Signaling Technology is a different kind of life science company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor. As a company of caring people driven by a devotion to facilitating good science, we are committed to doing the right thing for our customers, our communities, and our planet.
Cellectricon AB
Bronze Sponsor
At Cellectricon, we create new avenues for drug discovery. With a broad platform for in vitro neurobiology research, we provide outstanding value for our Clients through highly customized services delivering scientific excellence, innovation, and quality of the highest of standards.
Our services span the early discovery process where we help our Clients to obtain novel insights into disease biology and to identify targets and lead compounds with potential to produce first-in-class medicines.
Our unique discovery platform combines drug discovery expertise and disease area knowledge with cutting-edge technologies.
Our services are focused on accelerating target and lead discovery programs in the areas of Peripheral Neuropathies, Neuroinflammation, Neurodegeneration and Neuroplasticity. Our Neurotoxicity Testing Services support the early safety assessment of drug candidates.
GeneFrontier
Bronze Sponsor
GeneFrontier offers a revolutionary cell-free protein expression platform, PUREfrex®. This highly customizable system enables precise control at the molecular level, making it ideal for producing a wide range of proteins including difficult-to-express proteins as well as for high-throughput screening of therapeutic biologics. By seamlessly integrating with AI/ML, PUREfrex® accelerates protein engineering and optimization, driving innovation in the biologics field.
HUB Organoids
Bronze Sponsor
HUB Organoids is the global leader in patient-derived organoid technology. Our patented technology enables drug developers to identify and validate clinical candidates in a patient-relevant in vitro system. We disrupt the status quo and deliver superior therapeutic solutions to the world by bridging the gap between the lab and the clinic.
International N&H USA, Inc. (Roquette)
Bronze Sponsor
Roquette unites the proven expertise of Roquette Pharma Solutions with the acquisitions of Qualicaps and IFF Pharma Solutions — bringing together over 75 years of innovation in excipients, APIs, capsules, and drug delivery systems.
We provide comprehensive solutions for controlled release, immediate release, solubility enhancement, and nitrosamine mitigation strategies — leveraging deep polymer expertise, technical excellence, and a strong commitment to sustainable, compliant manufacturing practices.
Learn more at roquette.com.
IRBM
Bronze Sponsor
Founded in 2000 as Merck & Co's Italian R&D site and independent since 2010, IRBM has pioneered drug discovery for oncology, neurological disorders, infectious diseases, and rare conditions. Our scientists work across small molecules, peptides, and antibody therapeutics, delivering three approved drugs and over 30 clinical candidates. From a fully integrated research facility, we combine deep scientific expertise with agile, end-to-end capabilities. Our internal pipeline features two oncology assets and one antiviral program, reflecting our relentless commitment to pushing the boundaries of therapeutic science.
Lonza AG
Bronze Sponsor
Lonza is one of the world’s largest healthcare manufacturing organizations. Working across five continents, our global community of approximately 20,000 colleagues helps pharmaceutical and biotech companies to bring their treatments to market. We support our customers with a combination of technological insight, world-class manufacturing, scientific expertise, process excellence and innovation. Our work enables our customers to develop and commercialize their therapeutic discoveries, allowing their patients to benefit from life-saving and life-enhancing treatments.
In Advanced Synthesis, we apply more than 125 years’ expertise in classic and complex chemistry to the manufacturing of small molecules, highly potent APIs, antibody-drug conjugates and bioconjugates. Our integrated dry‑powder inhalation (DPI) development services, covering both small and large molecules, multiple enabling technologies, and end‑to‑end support from early development to commercial manufacturing, position Lonza as an industry leader in inhaled drug development.
-8a27b0.jpg?length=600&name=6a7e6884-41e8-4300-a295-b0b6c2ca8e87-2-5668375logo-Nova-Logo_2-COLOR-(1)-8a27b0.jpg){kind=logo}
Novo Bio (Advanced Instruments)
Bronze Sponsor
Advanced Instruments and Nova Biomedical have merged, uniting two innovation-driven organizations under a single, global brand. This strategic combination marks a significant milestone in our journey to deliver even greater value to our customers. By combining our strengths, we’re enhancing our ability to support your workflows, accelerate innovation, and provide world-class service across the biopharmaceutical and clinical markets.
Nova Biomedical is a global leader in healthcare diagnostics, bioprocessing technologies that support drug development, food and beverage analytical testing, and solutions for veterinary medicine. We are committed to advancing patient care and accelerating scientific discovery through the development of cutting-edge instrumentation and innovation. As the largest privately held in vitro diagnostics company in the United States and one of the fastest-growing worldwide, Nova serves customers in more than 100 countries. Our significant annual reinvestment in R&D fuels a robust pipeline of breakthrough technologies. Guided by our core values of customer centricity, ingenuity, collaboration, integrity and ownership & accountability, we foster a culture that inspires employee loyalty and earns enduring trust from our customers.
Optibrium
Bronze Sponsor
Optibrium develops exceptional software and AI solutions that help scientists advance their drug discovery projects. Cutting-edge science, backed up by rigorous research, underpins their intuitive software for compound design, optimisation and data analysis. Optibrium’s comprehensive in silico platform improves the speed, efficiency, and productivity of the chemistry discovery process and supports a worldwide customer base, including leading biopharma companies.
Optibrium was founded in 2009 and is headquartered in Cambridge, UK, with a US subsidiary, Optibrium Inc., based in Cambridge MA.
Pfanstiehl GmbH
Bronze Sponsor
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Amino Acids such as L-Arginine, Histidine, Glutamine and Methionine for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
Pion Inc
Bronze Sponsor
Pion supports the development of lifesaving and life-enhancing drugs by providing tools for drug developers, formulations scientists, and pharmaceutical production. For early-stage drug developers, our cutting-edge analytical technologies and services enable in vitro measurements of solubility, permeability, pKa and lipophilicity, providing essential data to improve candidate selection and formulations decisions for both oral and subcutaneous dosage forms. Later in development, high-pressure homogenizers enable particle size reduction and ensure material consistency from bench- to production-scale.
RedShift BioAnalytics Inc
Bronze Sponsor
RedShiftBio has developed a proprietary life sciences platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high-powered quantum cascade lasers that provide ultra-sensitive and ultra-precise measurements of molecular structure. These structural changes affect critical quality attributes governing the safety, efficacy, and stability of biomolecules. Utilizing its power to characterize conformational binding, structure with Tm, aggregation, concentration, and more, utilizing a label-free high-throughput method.
Alongside our commitment to further innovation in the formulations and development space, RedShiftBio also supports biopharmaceutical manufacturing with HaLCon, our bioprocess analytics platform, purpose-built to measure protein A titer in or at line within the bioreactor space. Eliminating the need for redundant testing from Octet, Cedex or waiting for off-line HPLC.
This combination of technologies is available to researchers in our fully automated AuroraTX and HaLCon systems, which are backed by a global network of sales, applications, service, and support teams to address all market needs.
Resolian
Bronze Sponsor
Resolian is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized analytical sciences and bioanalytical solutions. Over 500 experts across the U.S., U.K., China and Australia deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum.
Spera Pharma
Bronze Sponsor
SPERA PHARMA is a Japan‑based pharmaceutical CDMO providing CMC development and manufacturing services. The company leverages advanced structural and solid‑state analysis using 3D ED / MicroED, along with DIC‑based formulation technology for direct API capsule filling. Backed by know‑how from former leading‑pharma scientists and extensive global development experience, SPERA PHARMA supports highly potent APIs as well as high‑potency injectable products, including biologics. Working closely with regulatory and clinical partners, the company serves as a reliable gateway to Japan, enabling efficient development aligned with Japanese regulatory requirements.
Symeres B.V.
Bronze Sponsor
Symeres is a transatlantic drug discovery and development partner, combining proven expertise, adaptive thinking, and attentive collaboration to help customers realize the full value of their transformative therapies from inception to IND.
Operating across Europe and North America, Symeres brings together multidisciplinary teams spanning chemistry, biology, ADME-tox, and CMC under one integrated approach, delivering clear, continuous progress and reducing risk across the drug development journey.
WuXi AppTec
Bronze Sponsor
WuXi AppTec is a trusted partner and contributor to the
pharmaceutical and life sciences industries, providing R&D and
manufacturing services that help advance healthcare innovation.
With operations across Asia, Europe, and North America, we offer
integrated, end-to-end services through our unique CRDMO
(Contract Research, Development, and Manufacturing
Organization) platform. We are privileged to work alongside nearly
6,000 partners across 30+ countries, supporting their efforts to
bring breakthrough treatments to patients. Guided by our vision
that every drug can be made and every disease can be treated,
we are committed to advancing breakthroughs for patients—one
collaboration at a time.
Learn more at http://www.wuxiapptec.com
Network & Programme Sponsors
Aelius Biotech
Network & Programme Sponsor
Aelius biotech is a preclinical R&D Contract Research Organisation focused on advanced gastrointestinal and mucosal modelling for orally and pulmonary delivered therapeutics. Aelius Biotech’s flagship digestion and absorption model utilises a proprietary cell compatible mucus layer to allow co-incubation of digestive fluids with an absorptive Caco-2 monolayer to investigate absorption in the presence of small intestinal digestive fluids. Aelius Biotech provide human relevant gut models to improve early-stage prediction of;Drug product dissolution, solubility and release rates;Mucus permeation;and Epithelial absorption. This platform is particularly suited to evaluating oral formulation performance and novel delivery technologies. By combining the digestive components of the upper GI tract with an absorptive Caco-2 monolayer, the system can effectively assess;Modified release formulations;Novel biologic oral delivery approaches;and Permeation enhancers. Aelius biotech provides it’s customers with the data to de-risk formulation or candidate selection while reducing the industries reliance on animal testing to generate biorelevant preclinical data.
Almac
Network & Programme Sponsor
Operating from state-of-the-art facilities in the UK, US and Europe, Almac Pharma Services is a fully regulatory approved CDMO partnering with global pharmaceutical and biotechnology industries. With over 55 years' experience, we provide a comprehensive range of tailored solutions and access to a wealth of technical experts to support the delivery of your complex projects. Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. Our scientists can develop your clinical candidate into an optimum formulation and manufacture oral dose products for all stages of clinical trials. We specialise in the manufacture & primary packaging of oral dosage forms as well as customised secondary packaging for all drug products including ultra-low temperature drug products. Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options.
Axxam SpA
Presentation & Exhibition
Axxam S.p.A. is a Contract Research Organization (CRO) providing integrated early discovery services to pharma, biotech, start-ups, foundations, and academia. Axxam delivers integrated target-to-lead solutions (named DiscoveryMAXX), from AI-enabled target identification to wet-lab target validation, hit identification, and hit-to-lead, offereing also access to high-quality synthetic and natural compound collections. Leveraging state-of-the-art experimental platforms, including New Approach Methodologies (NAMs), Axxam enables efficient progression of high-quality candidates through early discovery. The same science-driven approach is also applied to identify new bioactive compounds across crop protection, animal health, food and beverage, pet food, cosmetic, and perfume industries. For more information, please visit www.axxam.com.
-(2).jpg-4157a1.png?length=600&name=0a034846-ea94-4bc4-b8a4-d9253e87f46c-2-5668375logo-Biolizard_black-(1)-(2).jpg-4157a1.png)
BioLizard
Network & Programme Sponsor
We help the life sciences industry to move from complex data to confident decisions, guided by clear, biology-driven insights. BioLizard partners with organizations of all sizes, from small pharmaceutical companies and startups to leading biotech and pharma companies, to extract meaningful insights from complex biomedical data. Bio|Verse®, our modular analytics platform, enables intuitive exploration, custom workflows, and scalable infrastructure built around your science.
Captisol
Presentation & Exhibition
Captisol is a derivatized beta cyclodextrin used in 18 approved products to date, including VEKLURY® (remdesivir) and KYPROLIS® (carfilzomib) to help solubilize & stabilize difficult to deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency.
Captisol has been clinically used in therapeutics across many routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation, and dermal.
Chemical Computing Group
Presentation & Exhibition
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG provides state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia.
.jpg?length=600&name=61ac7f24-46f1-4373-9564-8293c215c0a7-2-5668375logo-CDDV_L_BLUE_ON_WHITE_CMYK-(9).jpg)
Collaborative Drug Discovery, Inc.
Presentation & Exhibition
Collaborative Drug Discovery (CDD) provides an intuitive software suite extensively used by innovative biologists and chemists across academic, biotechnology, and pharmaceutical organizations. Its flagship platform, CDD Vault, enables researchers to securely manage and analyze both chemical and biological data through a user-friendly web interface. The platform supports entity registration, including small molecules, biologics, and complex modalities like ADCs, while offering robust inventory tracking, bioassay data management, SAR analysis, and experiment capture via its integrated Electronic Laboratory Notebook (ELN). CDD Vault also includes AI-powered tools for data mining and drug candidate prioritization, helping teams extract actionable insights more efficiently. Known for its intuitive design, strong performance, and secure collaboration workflows, CDD Vault facilitates seamless data sharing across internal teams and external partners. Founded in 2004, CDD today serves thousands of researchers worldwide, accelerating preclinical discovery and early-stage R&D efforts. Learn more at www.collaborativedrug.com
Dapu Biotechnology (DP-BIO)
Network & Programme Sponsor
DPBIO is a pioneering innovator based in California, specializing in high-throughput droplet microfluidic technology and providing cutting-edge life science solutions to researchers and industry leaders worldwide.
At DPBIO, we integrate advanced microfluidic technology with life sciences to develop comprehensive solutions, including microfluidic chips, instruments, and reagents. Our flagship products—such as the CytoSpark® High-throughput Screening System, OMNIdrop System—empower scientists in antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, viral quantification, and biopharmaceutical quality control.
Trusted by leading biotech and pharmaceutical companies, top-tier research institutions, and clinical laboratories worldwide, DPBIO is committed to advancing life sciences with high-performance analytical and detection systems. Our mission is to accelerate drug discovery, synthetic biology, biomedical research, and precision medicine, driving breakthroughs that transform life science innovation.
Lonza AG - Capsugel
Presentation & Exhibition
Capsugel provides high-quality capsules and innovative solutions for oral drug delivery and inhalation. Capsugel's expertise supports the optimization of formulations, offering tailored technologies and services to advance pharmaceutical and nutraceutical development worldwide. Capsugel's global network includes complete supply chain, regulatory, quality and application support to meet your needs with capsule manufacturing facilities in North America, Europe, India, China and Japan. Capsugel offers full lifecycle development and manufacturing (CDMO) for oral and inhalation drug products
Novalix
Network & Programme Sponsor
Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities. We work collaboratively with our clients to meet the most complex scientific challenges, and our innovative partnerships with leading instrument makers and academic institutions help us continually expand the possibilities of human health.
Onyx Scientific Limited
Network & Programme Sponsor
Onyx Scientific is the CDMO division of Ipca Laboratories, offering small molecule drug substance development and manufacturing services. Our MHRA-licensed sites in the UK offer early development of candidate APIs and manufacturing for clinical phases through to commercial supply. Dedicated solid-state and analytical chemistry teams expedite development activities at Onyx but are also available to provide full-service outsourced projects to complement or support your in-house campaigns. With a wealth of early development experience and success, our pragmatic, fit-for-purpose approach focuses on rapid process development and a view to future GMP campaigns. Where required, scale-up through Phase II towards commercial manufacture is retained either at Onyx or within the Group through transfer to our sister sites and colleagues in the USA and India.
Pelago Bioscience
Network & Programme Sponsor
At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage. Unlike traditional methods, CETSA allows us to assess drug-target interactions in physiologically relevant, unmodified cellular environments—so you can be confident that what you see in cells, you will also see in patients.
Our services rest on four pillars:
• Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks.
• Fast & Early Confidence: We deliver actionable insights in just 4-10 weeks, eliminating unnecessary complexities so you can make decisions faster.
• Insights & Progress: Our data supports compound prioritization and predicts future research steps, reducing project costs.
• Extended Team Support: We work as your dedicated partner, designing fit-for-purpose studies that align with your goals.
With Pelago, you gain more than just data;you gain a trusted partner in your discovery journey.
PharmaBlock
Network & Programme Sponsor
PharmaBlock is a fully integrated CRDMO providing research, development, and manufacturing services from early discovery to commercial production.
Founded in 2008, PharmaBlock has partnered with nearly all top 20 pharmaceutical companies and hundreds of biotech companies worldwide. The company supports small molecules and emerging modalities including peptides, oligonucleotides, ADCs, and targeted protein degraders.
Driven by innovation in chemistry and low-carbon manufacturing technologies，including continuous flow chemistry, micropacked bed hydrogenation, and biocatalysis，PharmaBlock helps partners accelerate development, ensure reliable quality and supply, optimize costs, and advance more sustainable pharmaceutical manufacturing.
Proteome Sciences plc
Network & Programme Sponsor
Proteome Sciences is a CRO specialising in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterise proteins and their associated post translational modifications. By using LC-MS2, SysQuant® and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
These key protein biomarkers can then be measured in a GCLP accredited Targeted Assay in a clinical trial, via a multiplexed assay of up to 100 proteins/sample.
New! We now offer Solvent Shift chemoproteomic analysis.
New! We have just opened a full service lab in San Diego!
New! New services based on TMT-32 plex available now!
Reaction Biology
Presentation & Exhibition
Reaction Biology is a consultative drug discovery and development CRO that elevates the standard for collaboration, scientific rigor, and data quality.
For 25 years, we've helped advance novel therapeutics by delivering reliable, timely data to 2,500+ clients worldwide. Hundreds of therapies submitted for IND were supported by our science, because a partner you can trust helps reduce risk at every milestone.
With four strategically positioned facilities across the US and Europe, an integrated assay portfolio spanning biochemical, cellular, biophysical, safety, and in vivo capabilities, and gold-standard methodologies backed by ISO 9001:2015 quality management, we deliver the speed and scientific rigor your program demands.
Let's discover together.
Semarion
Network & Programme Sponsor
Semarion is transforming adherent cell assays for next-generation drug discovery.
Our SemaCyte® platform turns adherent cells into barcoded, assay-ready, automation-friendly reagents, enabling researchers to multiplex cell models in the same well, miniaturise assays, and generate richer biological data from existing microplate workflows.
SemaCytes are ultra-miniaturised, optically barcoded microcarriers that function like microscopic Petri dishes. They carry small groups of adherent cells while preserving 2D morphology, can be handled with standard liquid handlers, cryopreserved for on-demand use, pooled for multiplexed assays, and decoded by high-content imaging.
By decoupling cell preparation from assaying and multiplexing cell models, SemaCytes help discovery teams reduce variability, remove scheduling bottlenecks, and increase data throughput by 10× without replacing existing automation or imaging infrastructure.
Semarion is based in Cambridge, UK and combines microfabrication, materials science and cell biology to make adherent cell assays more scalable, reproducible and automation-ready. We work with pharmaceutical companies and technology partners across phenotypic screening, antibody discovery, compound profiling and advanced in vitro models.
X-Chem
Network & Programme Sponsor
Since 2009, X-Chem has led the way in DNA-encoded library (DEL) science and continues to evolve drug discovery. By combining DEL data with medicinal chemistry and computational sciences, we transform data into insights that accelerate and improve small molecule discovery. We partner with pharma and biotech innovators to deliver the clarity and confidence needed to move programs forward.
Yokogawa Fluid Imaging Technologies
Network & Programme Sponsor
FlowCam uses Flow Imaging Microscopy to rapidly acquire digital images of subvisible and submicron particles to provide particle count, size, and morphology. Due to its exceptional image quality, FlowCam has become an indispensable tool in biotherapeutics research, formulation, and development for proteins, nano-drug delivery systems, and cell and gene therapy products.
Start-Ups
60Nd
Start Up Zone
60Nd is a European biotech company and spin-off from Universidad Carlos III de Madrid, pioneering the field of mechanomedicine. We develop technology and services that bring mechanical reality into biomedical research, enabling scientists and pharmaceutical companies to understand how physical forces drive disease, tissue aging, and drug response at the cellular level.
Our core platform, NeoMag, is the first commercially available system for non-invasive magneto-mechanical stimulation of cells and biological tissues. Using precision magnetic actuation, smart biocompatible substrates, and AI-driven software, NeoMag applies controlled, dynamic, and reversible mechanical forces to living samples without direct contact. It is compatible with conventional microscopy and integrates with leading laboratory instrumentation.
NeoMag addresses a critical blind spot in drug discovery and preclinical validation: while all key biological processes are influenced by mechanics, current in vitro models ignore it entirely. This limits the predictive value of cell-based assays, contributing to the high failure rates and escalating costs of drug development.
60Nd works with research institutions and pharmaceutical companies both as a technology provider and as a specialized partner for mechanobiology-driven assay design and execution, delivering differentiated evidence packages that conventional testing cannot produce.
Backed by a EIC Transition grant from the European Commission and validated through pilot programs at institutions including UCSF, Imperial College London, and UCL, 60Nd is building the standard platform for mechanobiology in drug discovery, cancer research, fibrosis, neurodegeneration, and organ-on-chip applications.
Acoustofab
Start Up Zone
Acoustofab Ltd specialises in advanced acoustic levitation systems designed for fully contact-free, software-defined automation in the handling of droplets, powders, and microscale samples. By using precisely controlled acoustic fields, our technology enables materials to be manipulated in mid-air without physical contact, significantly reducing contamination risks and preserving sample integrity.
Our platforms offer highly programmable, repeatable control, allowing researchers and industry users to design complex workflows with precision and flexibility. This makes them particularly valuable in applications where sterility, sensitivity, or material loss are critical concerns, including life sciences, drug discovery, proteomics, advanced materials, and chemical processing.
Acoustofab’s solutions are built to integrate seamlessly into modern laboratory and industrial environments, supporting innovation through automation and digitisation. By removing traditional physical constraints, we empower users to explore new experimental possibilities and improve reproducibility, efficiency, and data quality across a wide range of scientific and commercial applications.
Avenue Biosciences
Start Up Zone
Avenue Biosciences is a transatlantic biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Avenue Biosciences has developed a protein engineering platform for measuring and modulating the efficacy of the protein secretory pathway, a critical bottleneck affecting the development and manufacturing of therapeutic proteins.
DendroPharm
Start Up Zone
DendroPharm is a young innovative pharmaceutical company located in Berlin, specializing in the development of targeted drug delivery systems, to transport active pharmaceutical ingredients directly to the site of disease or pain, thereby increasing therapeutic efficacy while reducing systemic side effects.
At the core of the technological platform are patented amphiphilic dendritic nanocarriers that can be loaded with already established active pharmaceutical ingredients (APIs). This creates opportunities for accelerated regulatory pathways, including the Generics-Plus and 505(b)(2) approaches. In this way, DendroPharm combines scientific excellence with an economically scalable development model.
One example from our development pipeline is an encapsulated opioid that is restricted from crossing the blood-brain barrier. This significantly reduces risks such as addiction and common side effects, including constipation. Additionally enabling lower dosages, as treatment occurs locally rather than systemically. Against the backdrop of the opioid crisis, this approach addresses not only a highly relevant medical and societal demand for safer pain therapies, but also represents a significant market opportunity within the global pain management and opioid therapeutics sector.
At its company site DendroPharm operates GMP-compliant manufacturing and analytical facilities. In addition to our own research and product development activities we provide contract manufacturing services, e.g. formulation development, small-batch manufacturing, test sample production, and analytical testing, while also acting as a scientific cooperation partner.
DendroPharm’s corporate culture is characterized by flat hierarchies, interdisciplinary collaboration, and an open, collegial working environment. The team brings together chemists, engineers, biologists, and experts from various other disciplines. Furthermore, DendroPharm is actively engaged in training interns and young researchers from universities in Berlin.
Eben Build
Start Up Zone
Ebenbuild GmbH is a Munich-based deep-tech healthcare company developing physics-based, patient-specific digital twins of the human lung. The company’s platform transforms standard CT data into validated digital lung models, making lung mechanics and function quantitatively accessible at the individual patient level.
By enabling detailed analysis of airflow, tissue mechanics, and aerosol transport across the entire lung, Ebenbuild provides a robust technological foundation for applications in pharmaceutical research and development as well as for regulated clinical decision support in respiratory care.
Based on this technology, Ebenbuild developed Twinhale, a simulation platform designed to support the development of inhaled drugs and drug–device combination products. Twinhale integrates CT-derived lung geometries, breathing patterns, and in vitro aerosol characteristics to predict regional lung deposition and the local dose at the site of action. By simulating structured virtual patient cohorts, the platform enables in silico trials that quantify variability in drug deposition across patient populations. These simulations support key development decisions, including device selection, formulation optimization, dose robustness assessments, and the generation of model-integrated evidence for bioequivalence, bridging, and regulatory discussions.
Ebenbuild’s approach replaces assumptions with physics-based evidence, supporting more informed decisions in drug development and, over time, in the clinical management of patients with severe pulmonary diseases.
AI & Digitalisation Sponsor
Clarivate
AI & Digitilisation Sponsor
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. Our connected data, deep expertise and intelligence platforms empower life sciences and healthcare companies to deliver safe, effective and commercially successful treatments to patients faster. Clarivate is home to Cortellis, solutions for real world data, medtech, market access and commercialization and deep consulting expertise.
Genomics
AI & Digitilisation Sponsor
Genomics is a science-led transatlantic TechBio generating genetic insights from large-scale omics data using proprietary analytics to accelerate target discovery and validation. Today, we are collaborating with some of the world’s leading biotech and pharma organisations powering their human genetics teams with our research infrastructure and using agentic AI to enable better collaboration across R&D teams.
Our Esteemed Sponsors for NextGen Omics & Spatial Biology US 2025
Platinum Sponsors
10x Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Bruker Spatial Biology
Platinum Sponsor
Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology.
The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity.
Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing.
For more information, visit www.BrukerSpatialBiology.com.
Gold Sponsors
ariadne.ai
Gold Sponsor
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
Cell Signaling Technology
Gold Sponsor
CST® is a privately-owned, global company headquartered in Danvers, Mass., USA. Founded in 1999 and still led by research scientists. We are actively engaged in the development of products and technologies that facilitate signaling analysis and mechanistic cell biology and cancer research.
Miltenyi Biotec, Ltd.
Gold Sponsor
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.
Quantum-Si
Gold Sponsor
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Singular Genomics
Gold Sponsor
Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues
Vizgen
Gold Sponsor
Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Vizgen is headquartered in Cambridge, Massachusetts, and can be found online at www.vizgen.com and www.ultivue.com. Connect on social media Twitter, LinkedIn and Facebook.
Silver Sponsors
ACD, Bio-Techne
Silver Sponsor
ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine.
Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily.
Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.
Ardigen S.A.
Silver Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Complete Genomics
Silver Sponsor
Complete Genomics is a pioneering life sciences company offering innovative, comprehensive sequencing solutions, including sample/library preparation, lab automation, sequencing, and data analysis. Our sequencing portfolio features a full range of sequencers designed to meet low, medium, and high throughput needs, all powered by our proprietary DNBSEQ technology. To date, over 9,700 publications have utilized DNBSEQ technology across a broad spectrum of applications.
As the exclusive distributor of STOmics products in North America, Complete Genomics provides access to Stereo-seq technology—the only spatial transcriptomics solution worldwide capable of exploring the entire transcriptome at true single-cell resolution.
To learn more, visit https://www.completegenomics.com
GENEWIZ from Azenta Life Sciences
Silver Sponsor
As a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Hamilton
Silver Sponsor
Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs.
Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada;Franklin, Massachusetts;Timișoara, Romania;Bonaduz, Switzerland;and subsidiary offices throughout the world.
Lunaphore Technologies SA, a Bio-Techne company
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Navinci
Silver Sponsor
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
NeoGenomics Laboratories
Silver Sponsor
NeoGenomics is a premier cancer diagnostics company, specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. We partner with pharmaceutical clients from discovery to commercialization with broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
Parse Biosciences
Silver Sponsor
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Sapient Bioanalytics
Silver Sponsor
Sapient is a leader in multi-omics discovery, providing bespoke services for proteomics, metabolomics, lipidomics data generation and delivering insights that enable biopharma sponsors to go beyond the genome to accelerate precision drug development.
Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping and integrative analyses with other omics and real-world data.
Aided by our proprietary Human Biology Database — comprising data from tens of thousands of samples in which we can mine for and validate biomarkers and targets — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.
Scale Biosciences
Silver Sponsor
Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
Single Cell Discoveries
Silver Sponsor
Single Cell Discoveries is a Contract Research Organization (CRO) specializing in innovative single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics. Single Cell Discoveries delivers high-impact insights to biopharmaceutical companies, healthcare systems, and academic research centers worldwide. Single Cell Discoveries' mission is to accelerate groundbreaking research by developing and providing state-of-the-art single-cell technologies as a service.
.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Bronze Sponsors
Aspect Analytics
Bronze Sponsor
Aspect Analytics develops enterprise software to analyze and integrate spatial omics data. Spatial technologies are steadily maturing into a key enabler in drug development, biomarker discovery, and life science research. With spatial omics datasets commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology. Aspect Analytics bridges the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key spatial omics-based applications. Our software can (i) extract maximal knowledge from spatial data, including co-registration with different modalities, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing spatial multi-omics data into a single view, collaborative platform.
Atrandi Biosciences
Bronze Sponsor
Atrandi Biosciences is a pioneering life sciences tool company transforming single-cell analysis with Semi-Permeable Capsule (SPC) technology. SPCs redefine how single-cell research is done, enabling multi-step, high-throughput workflows while maintaining true single-cell resolution. Unlike conventional methods, SPCs allow researchers to perform multiomic assays seamlessly, unlocking deeper insights into biology. Founded by leading scientists and driven by a mission to simplify research and advance discovery, Atrandi is shaping the future of single-cell analysis and empowering scientists worldwide.
Beckman Coulter
Bronze Sponsor
We are a life sciences company that provides an extensive portfolio of solutions for workflow innovation, lab automation of routine tasks/complex methods, and software solutions to advance your research.
Our lab automation solutions and genomic reagents portfolio facilitate seamless processes for DNA/RNA clean-up, size selection, extraction, and sample preparation for NGS, RNA-seq, and single-cell transcriptomics. By integrating our advanced solutions into your lab, you can achieve high-quality, reproducible data, empowering your AI and machine learning models.
Becton Dickinson Biosciences
Bronze Sponsor
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because we’ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare. For more information, please visit: www.bdbiosciences.com
CS Genetics
Bronze Sponsor
CS Genetics delivers simplicity in a world of complex, time-consuming and expensive single cell genomics workflows. Our nimble, experienced team understands that tomorrow’s discoveries require technology that is simple to adopt and easy to use with near-limitless scalability.
Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, Kinetic Confinement assay that plugs seamlessly into any molecular biology laboratory. This simplicity also enables an affordable price point so researchers will no longer have to limit the scale of their studies.
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
Hawk Biosystems
Bronze Sponsor
HAWK Biosystems is an innovative biotechnology company based in Bilbao, Spain, and a spin-off from prestigious institutions such as Cancer Research UK (CRUK) and the Francis Crick Institute in London. Founded in 2018 by an exceptional team of scientists and business leaders, HAWK has rapidly positioned itself at the forefront of spatial biology, providing ground-breaking solutions for the analysis of protein functions in tissue.
At HAWK Biosystems, our mission is to develop advanced diagnostic systems that accelerate the progress of personalized medicine, focusing on critical diseases such as cancer. Our cutting-edge technology, QF-Pro®, is a revolutionary platform that enables precise, quantitative analysis of protein functions at a sub-pixel resolution. Unlike traditional techniques, QF-Pro® is capable of identifying protein-protein interactions and post-translational modifications within tissue samples at a resolution of less than 10 nanometers. This innovation provides clinicians and researchers with reproducible, robust, and unbiased data, which has demonstrated significant clinical value. For instance, QF-Pro® has been validated in a study to predict patient response to PD-1/PD-L1 inhibitors in lung cancer, demonstrating its potential to significantly improve treatment outcomes by potentially tripling response rates and doubling survival rates.
Leica Microsystems & Leica Biosystems
Bronze Sponsor
Leica Microsystems develops and manufactures microscopes and scientific instruments for
the analysis of microstructures and nanostructures. Widely recognized for optical precision
and innovative technology, the company is one of the market leaders in compound and stereo
microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy.
Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Levitasbio
Bronze Sponsor
LevitasBio is dedicated to advancing science and
human health by providing researchers with new
and powerful methods for sample preparation and
characterization. The LeviCell platform is a
first-in-class cell enrichment solution powered
by a proprietary, label-free, and gentle Levitation
Technology. Our unique solution generates
high-quality samples while preserving the cells’
native state, enabling researchers across multiple
scientific disciplines to uncover true biology.
Accelerate Scientific Discovery With the Power of
Levitation Technology
.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png){kind=logo}
RareCyte
Bronze Sponsor
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Zifo Technologies
Bronze Sponsor
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and qualit
Network & Programme Sponsors
Aliri Bioanalysis
Network & Programme Sponsor
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
.svg){kind=logo}
BioLizard
Network & Programme Sponsor
At BioLizard, we “think data” and “speak biology”, partnering with our clients to transform lives. Our expert team combines deep biological knowledge with cutting-edge AI and bioinformatics to tackle complex data challenges in human and animal health. Through our AI-native Bio|Verse platform, we accelerate biomarker discovery and enable actionable insights for modern drug development. With a global presence, we deliver tailored solutions in data management, bioinformatics, and AI to drive your data-driven strategy to biotech, pharma and diagnostic companies. Let’s shape the future of life sciences together—connect with BioLizard today!
.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png){kind=logo}
Discovery Life Sciences
Network & Programme Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png){kind=logo}
Elucidate Biotechnologies
Network & Programme Sponsor
Elucidate Bio provides multi-modal spatial biology services, enabling same-tissue imaging of DNA, RNA, and protein with single-cell spatial resolution. Powered by technology licensed from Sizun Jiang at Harvard Medical School/BIDMC, we specialize in single-slide spatial proteomic, transcriptomic, and genomic data
generation and analysis. With rigorous quality control, we deliver high-quality data, detailed analysis, and actionable insights to advance biomarker discovery, therapeutic development, and precision medicine. Contact Elucidate Bio to explore innovative spatial pipelines tailored to your program needs.
Psomagen
Network & Programme Sponsor
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Scailyte
Network & Programme Sponsor
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio.
The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in various clinical projects in immunology and oncology.
.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)
Stellaromics
Network & Programme Sponsor
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.
The Stellaromics Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples at an unprecedented resolution. These breakthroughs, based on the company's STARmap and RIBOmap technologies, greatly expand upon applications of traditional 2D methods by offering a true 3D perspective, providing researchers with a deeper understanding of tissue organization, cellular interactions, and disease mechanisms.
Via Scientific
Network & Programme Sponsor
Via Scientific: AI-Powered Acceleration for Multi-Omics & Spatial Biology
AI-Driven Bioinformatics Innovation: Via Foundry, Via Scientific’s AI-powered platform, accelerates multi-omics research by eliminating bioinformatics bottlenecks. It enables research teams to build custom analysis pipelines without coding, automating data processing so scientists can focus on discovery. Foundry acts as a “force multiplier” for biomedical research, dramatically reducing time to insights.
Unified Multi-Omics & Spatial Insights: Designed for multi-omics and spatial biology, Via Foundry integrates genomics, transcriptomics, proteomics, and spatial data into a single platform. This fusion reveals deep biological insights missed by siloed analyses. With advanced visualization tools, Foundry handles large, complex datasets—accelerating discovery and development.
Empowering Next-Gen Research Collaboration: Built by scientists for scientists, Via Foundry upholds rigorous standards while enabling seamless collaboration across teams and long-term studies. With flexible deployment in the cloud or on-premises, it is trusted across academia, biotech, pharma, and healthcare. Combining AI-driven technology with an intuitive design, Via Scientific empowers researchers to unlock insights faster, more reliably, and at scale.
Visiopharm
Network & Programme Sponsor
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows.
Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Washington University
Network & Programme Sponsor
The McDonnell Genome Institute integrates cutting-edge ‘omics technologies and over 30 years of expertise to support your needs as your trusted partner. Explore our comprehensive solutions, including NGS, gene editing, stem cell biology, proteomics, and high-content imaging — custom-tailored to advance your research.
Start-Ups
